Summary
We studied renal function in nine patients with disseminated testicular carcinoma before and after remission-induction and maintenance therapy with a drug combination containing cis-platinum. The median glomerular filtration rate (GFR) decreased during remission-induction therapy from 146 to 118 ml/min. No effect of cumulative toxicity on the median GFR was found during maintenance therapy, nor did the median GFR improve. The median effective renal plasma flow (ERPF) decreased during the total period from 705 to 514 ml/min. No significant changes in median filtration fraction (FF) and serum creatinine were observed. It is suggested that intrarenal hemodynamic effects are important in the nephrotoxicity of cis-diamminedichloride platinum (CDDP).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balint P, Fekete A, Harza T (1969) Mercuric chloride-induced renal failure and intrarenal distribution of blood flow. Acta Physiol Acad Sci Hung 36: 193
Brenner BM, Deen WM, Robertson CR (1976) Glomerular filtration. In: The kidney, vol I. Saunders, Philadelphia, p 256
DeConti RC, Toftness BR, Lange RC, Creasey WA (1973) Clinical and pharmalogical studies with cis-diamminedichloroplatinum (II). Cancer Res 33: 1310
Dentino M, Luft FC, Yum MN, Williams SD, Einhorn LH (1978) Long-term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 41: 1274
Donker AJM, Van der Hem GK, Sluiter WJ, Beekhuis H (1977) A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20: 97
Einhorn LH, Donohue J (1977) cis-Diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293
Flamenbaum W, McNeil JS, Kotchen TA, Saladino AJ (1972) Experimental acute renal failure induced by uranyl nitrate in the dog. Circ Res 31: 682
Gonzalez-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS (1977) The renal pathology in clinical trials of cis-platinum(II)diamminedichloride. Cancer 39: 1362
Highby DJ, Wallace HJ, Albert DJ, Holland JF (1974) Diamminodichloroplatinum: A phase I study showing responses in testicular and other tumors. Cancer 33: 1219
Hollenberg NK, Adams DF, Oken DE, Abrams HL, Merrill JP (1970) Acute renal failure due to nephrotoxins. Renal hemodynamic and angiographic studies in man. N Engl J Med 282: 1329
Lippman AJ, Helson C, Helson L, Krakoff IH (1973) Clinical trials of cis-diamminechloroplatinum (NSC-119875). Cancer Chemother Rep 57: 191
Piel IJ, Perlia CP (1975) Phase II study of cis-dichlorodiammineplatinum (II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies. Cancer Chemother Rep 59: 995
Ryan R, McNeil JS, Flamenbaum W, Nagle R (1973) Uranyl nitrate-induced acute renal failure in the rat: Effect of varying doses and saline loading. Proc Soc Exp Biol Med 143: 289
Stark JJ, Howell SB (1978) Nephrotoxicity of cis-platinum(II)dichlorodiammine. Clin Pharmacol Ther 23: 461
Stoter G, Sleijfer DT, Vendrik CPJ, Schraffordt Koops H, Struyvenberg A, Van Oosterom AT, Brouwers ThM, inedo HM (1979) Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma. Lancet 1: 941
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meijer, S., Mulder, N.H., Sleijfer, D.T. et al. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. Cancer Chemother. Pharmacol. 8, 27–30 (1982). https://doi.org/10.1007/BF00292867
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00292867